Endo International PLC (ENDP.OQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Validea
$12.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo International PLC completes acquisition of Grupo Farmaceutico Somar


Thursday, 24 Jul 2014 04:15pm EDT 

Endo International PLC:Completes acquisition of Grupo Farmaceutico Somar(Somar), privately owned specialty pharmaceuticals company based in Mexico City.Combination of Somar and Endo advances Endo's position as global specialty healthcare company.It also establishes a platform for growth in key emerging markets in Latin America. 

Company Quote

16.98
1.39 +8.92%
1 Jul 2016